When Cancer Immunotherapy Silences the Thyroid Twice: A Rare One-Two Endocrine Blow
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine